Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from TMO

Is Mettler-Toledo Stock Underperforming the S&P 500?

Although Mettler-Toledo has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Do Wall Street Analysts Like Thermo Fisher Scientific Stock?

While Thermo Fisher Scientific has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Champions Cup final will have independent TV director in charge

An independent director will be in charge of the Champions Cup final TV coverage after Bath were left unhappy some camera angles were unavailable to the TMO in their semi-final loss

The Guardian - UK

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

MarketBeat

What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release

Thermo Fisher Scientific will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

Barchart

Waratahs blow it to suffer Super Rugby Pacific Blues

The NSW Waratahs have been left to lament squandering half a dozen try-scoring chances in a 35-20 Super Rugby Pacific loss to the Blues in Sydney.

AAP

Read news from The Economist, FT, and more,
with one subscription

Steve Borthwick admits England are ‘hurting’ after worst ever Six Nations

England produced their best performance of the competition as they fell to a late 48-46 loss to France, which saw them finish in fifth with one win.

The Independent UK

France flanker Oscar Jegou cited over alleged gouging incident in Scotland defeat

Jegou appeared to make contact with the eye of Scotland’s Ewan Ashman at a maul

The Independent UK

Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish?

Although Thermo Fisher Scientific has underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.

Barchart

What to Expect From Thermo Fisher Scientific's Next Quarterly Earnings Report

Thermo Fisher Scientific will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Barchart

Tommy Freeman hat-trick topples Bath and sends Northampton to Prem summit

An understrength Northampton ran in six tries at the Rec to leapfrog their rivals in the table and inflict Bath’s first home Prem defeat in more than a year

The Guardian - UK

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE:TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test.

Benzinga

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Institutions Love These 3 Companies, Should You As Well?

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

MarketBeat

These 3 Stocks Are Using Buybacks to Signal Market Confidence

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

Benzinga

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities

Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other performance-based payments.

Benzinga

Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Thermo Fisher Scientific Inc (NYSE:TMO) reported better-than-expected earnings for the third quarter on Wednesday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49.

Benzinga

Thermo Fisher Integrates OpenAI To Speed Drug Development

Thermo Fisher Scientific Inc. (NYSE:TMO) stock is trading higher on Thursday. The company announced plans to use artificial intelligence (AI) with OpenAI.

Benzinga

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

The Independent UK

Nathan Jibulu scores on debut as Sale kick off season with win over Gloucester

Sale 27-10 Gloucester: The hosts kickstarted the new Gallagher Prem season with a bonus-point win

Evening Standard

Women's Rugby World Cup: France forward to appeal 12-game ban for biting

Les Bleues face the Red Roses in the last four this weekend

Barchart

Is Thermo Fisher Scientific Stock Underperforming the Dow?

Thermo Fisher Scientific has lagged behind the Dow Jones Industrial over the past year, but analysts maintain a strong bullish outlook on its future performance.

Benzinga

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.